FORTE Study Update: May 2023

May 10 2023

FORTE has accrued over 550 participants! 11 activated sites accrued participants in April 2023!

NRG-CC005/FORTE Coordinator: Talking Points

The FORTE study team has created talking points for research professionals containing tips and tricks to assist with accrual efforts. This document contains a list of points to discuss when approaching potential participants, along with items to review should the patient express interest in consenting to this trial. The talking points also list common concerns participants have expressed when approached about FORTE. The document is posted on CTSU under NRG-CC005 > Protocol Related Documents.

Review the NRG-CC005/FORTE Coordinator Talking Points to learn from successfully accruing sites and coordinators!

Register for the next FORTE Site Call happening virtually on May 17!

Accrual Updates and Milestones (as of April 30, 2023)

Top accruing sites:

  • Kaiser Permanente – Vallejo – 316 accrued
  • UPMC-Presbyterian Hospital – 105 accrued
  • Park Nicollet Clinic - Saint Louis Park – 58 accrued

Most recent randomizations:

  • Kaiser Permanente-Vallejo – April 28, 2023
  • Regions Hospital – April 28, 2023
  • Essentia Health Cancer Center – April 28, 2023

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:

1(800) 477-7227 

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.